© 2004

Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

  • Masao Omata
  • Kiwamu Okita
Conference proceedings

Table of contents

  1. Front Matter
    Pages I-XI
  2. Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

    1. Front Matter
      Pages 1-1
  3. Lamivudine Therapy for Hepatitis B

    1. Front Matter
      Pages 23-23
    2. Naoya Kato, Suzane Kioko Ono-Nita, Masao Omata
      Pages 25-31
    3. Takeshi Okanoue, Kohjiro Mori, Toshihiko Kirishima, Masahito Minami
      Pages 38-44
  4. New Anti-Virals: HBV

    1. Front Matter
      Pages 45-45
    2. Man-Fung Yuen, Ching-Lung Lai
      Pages 47-56
    3. Deborah DeHertogh, Richard Colonno, William Fiske, Anne Cross
      Pages 63-73
  5. Therapy for Hepatitis B and Prevention of HCC

  6. HCV Replicon System

    1. Front Matter
      Pages 95-95
    2. Nobuyuki Enomoto, Naoya Sakamoto, Masayuki Kurosaki, Shinya Maekawa, Yoko Tanabe, Tsuyoshi Yamashiro et al.
      Pages 97-107
    3. Michael Frese, Volker Lohmann, Thomas Pietschmann, Artur Kaul, Nicole Krieger, Jens Bukh et al.
      Pages 108-122
    4. Christoph Seeger, Qing Zhu, Ju-Tao Guo
      Pages 123-130
  7. New Anti-Virals: HCV

    1. Front Matter
      Pages 131-131

About these proceedings


The liver has an important role in nutritional homeostasis, and it is well known that liver diseases can lead to abnormalities in the nutrient metabolism and to subsequent malnutrition. Because malnutrition is particularly prevalent in patients with liver cirrhosis, proper nutritional assessment and support for cirrhotic patients is essential. This collection of research and clinical findings on nonalcoholic steatohepatitis (NASH) and nutritional therapy contains significant new findings in several fields. As NASH frequently causes liver cirrhosis, the nutritional aspects of its treatment are discussed. Other areas covered include nonalcoholic fatty liver, the role of leptin in the pathogenesis of NASH, restricted diets and exercise therapy, mammalian targets of the peptide rapamycin, and genetic factors influencing the development of NASH. This book is intended to be of particular relevance to researchers and those practicing in the field.


Carcinom Hepatitis B Hepatitis C Hepatocellular carcinoma infection viral infection virus

Editors and affiliations

  • Masao Omata
    • 1
  • Kiwamu Okita
    • 2
  1. 1.Department of Gastroenterology Graduate School of MedicineThe University of TokyoTokyoJapan
  2. 2.Department of Gastroenterology and HepatologyYamaguchi University School of MedicineYamaguchiJapan

About the editors

Kiwamu Okita
Professor, Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine

Bibliographic information

  • Book Title Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma
  • Editors M. Omata
    K. Okita
  • DOI
  • Copyright Information Springer-Verlag Tokyo 2004
  • Publisher Name Springer, Tokyo
  • eBook Packages Springer Book Archive
  • Hardcover ISBN 978-4-431-40280-0
  • Softcover ISBN 978-4-431-67975-2
  • eBook ISBN 978-4-431-53977-3
  • Edition Number 1
  • Number of Pages XI, 295
  • Number of Illustrations 0 b/w illustrations, 0 illustrations in colour
  • Topics Hepatology
  • Buy this book on publisher's site